A TWO-JUDGE bench of the Supreme Court, on August 18 afternoon, issued an order on the legal code for the marketing of medicines.The Federation of Medical and sales Representatives’ Associations of India (FMRAI), had filed a petition in the court urging the government to enforce a legal code for marketing of medicines.The Indian media, however, has distorted facts and misreported the issue by selectively highlighting the issue of perks given to doctors to improve the sales of one product, Dolo-650, an antipyretic drug.Dolo-650, produced and marketed by Micro Labs, contains 650 mg of parace